NCT01086436View on ClinicalTrials.gov

Study to Evaluate the Safety of Rotarix™ in Chinese Children

PHASE1CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

March 13, 2010

Primary Completion Date

April 16, 2010

Study Completion Date

April 16, 2010

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Rotarix ™

Oral, single dose

BIOLOGICAL

Placebo

Oral, single dose

Trial Locations (1)

545200

GSK Investigational Site, Liucheng County

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01086436 - Study to Evaluate the Safety of Rotarix™ in Chinese Children | Biotech Hunter | Biotech Hunter